According to the edition of Sciencedaily, a group of neuroscientists from the Medical center at Georgetown University has developed and even has already successfully tested a medicine which reduces the accumulation of toxic proteins and other degradation products. Thus, it is possible to achieve the prevention and treatment of neurodegenerative conditions like Parkinson’s and Alzheimer’s, rehabilitation after violation of motor functions after stroke.
On 22 October at the international conference of the society of neuroscientists in Chicago, the experts presented the results of the tests of the substance under the code name CM101. Connection CM101 stimulates the system of excretion from the brain damaged folded proteins and toxic products. Among them there are Alfa-synuclein, Tau and beta-amyloid responsible for the development of a number of neurodegenerative processes in the Central nervous system.
Very low dose CM101 increases the excretion of proteins of neurons in the brain for a few hours. Just enough to ensure removal of neurotoxic proteins from cells and intercellular space, — says the candidate of medical Sciences, lead author and Professor of neurology, Georgetown University Charbel Moussa.
Current work is continuation of researches of scientists about how agents known as tyrosine kinase inhibitors, can cause to enhance the removal of protein and potentially stop neurodegenerative diseases. Previous work has led experts to clinical trials of the two drugs against cancer, which are inhibitors of tyrosine kinases (TKS) of “Nilotinib and Bosutinib”. These two drugs are assigned to patients for the treatment of leukemia in doses that are 10 times higher than what is needed to start a cleaning from accumulation of protein in neurons.
During the study of drugs and their effects on metabolic processes, the researchers found that 2 of the above-mentioned drug inhibit various tyrosine kinases of the brain, which increases the excretion of toxic products. A leading role in this process is the number of molecules, synthesizing scientists and received CM101.
We “redesigned” drugs for the treatment of cancer in order to help people to get rid of neurodegenerative disorders. Our research shows that this strategy works in even the neurons that are affected, but also died under the influence of toxins.
CM101, as scientists assure, passed extensive testing in several series of tests on laboratory animals who had induced neurodegenerative diseases. In most cases, been able to achieve maximum ability to remove protein and improve brain functions. Animals also have improved coordination and memory. By the way, we constantly inform about the success of this kind of research, so please subscribe to our channel Telegramto be aware of.
See also: Scientists have found a brain area, which is emerging Alzheimer's disease
The next step in the work is the study of the toxicity of the drug and identify its side effects. We cannot exclude the possibility of impact of the drug on other organs and tissues, particularly the bone marrow and the hematopoietic system, since the drug has a “protivoallergicheskoe roots.” As soon as the security CM101 is proven, will begin large-scale testing of a new drug on humans.